Event Brief
Mar 31, 2026 at 10:07 PM ET
Lotte Biologics signs CDMO deal with U.S. firm
By The BriefBrief
Lotte Biologics partners with a U.S. company for antibody drug substance production.
WHO: Lotte Biologics Co.
WHAT: signed a CDMO deal for antibody drug substance
WHEN: Mar 31, 2026 at 9:35 PM ET
WHERE: Seoul
WHY: to enhance production capabilities for antibody drugs
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21430 of 21430
Same format. Every time.
Continue reading — sign in or create a free account with
